Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares IssuedShares OutstandingShares RepurchasedShort-Term Debt issuances
Ratios

Cytek Biosciences (CTKB) Shares Issued (2020 - 2025)

Historic Shares Issued for Cytek Biosciences (CTKB) over the last 6 years, with Q2 2025 value amounting to $664000.0.

  • Cytek Biosciences' Shares Issued rose 3253.49% to $664000.0 in Q2 2025 from the same period last year, while for Sep 2025 it was $711000.0, marking a year-over-year decrease of 4725.52%. This contributed to the annual value of $1.0 million for FY2024, which is 3085.83% down from last year.
  • As of Q2 2025, Cytek Biosciences' Shares Issued stood at $664000.0, which was up 3253.49% from $39000.0 recorded in Q1 2025.
  • Over the past 5 years, Cytek Biosciences' Shares Issued peaked at $215.4 million during Q3 2021, and registered a low of $8000.0 during Q4 2024.
  • Moreover, its 5-year median value for Shares Issued was $283500.0 (2022), whereas its average is $13.8 million.
  • Its Shares Issued has fluctuated over the past 5 years, first soared by 22660736.84% in 2021, then plummeted by 9989.51% in 2022.
  • Quarter analysis of 5 years shows Cytek Biosciences' Shares Issued stood at $215.4 million in 2021, then plummeted by 99.92% to $168000.0 in 2022, then surged by 102.98% to $341000.0 in 2023, then plummeted by 97.65% to $8000.0 in 2024, then surged by 8200.0% to $664000.0 in 2025.
  • Its last three reported values are $664000.0 in Q2 2025, $39000.0 for Q1 2025, and $8000.0 during Q4 2024.